Paclitaxel/ramucirumabAnorexia and hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1834卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87406-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：214 / 214

相关论文

共 50 条

[1] Paclitaxel/ramucirumabInterstitial pneumonia and hypertension: 2 case reports
Reactions Weekly, 2019, 1740 (1) : 258 - 258
[2] Paclitaxel/quetiapinePneumonitis: 2 case reports
Reactions Weekly, 2008, 1211 (1) : 25 - 25
[3] Nedaplatin/paclitaxel/rivoceranibHand foot syndrome, hypertension and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1951 (1) : 262 - 262
[4] Paclitaxel/prednisoneLack of benefit: 2 case reports
Reactions Weekly, 2021, 1853 (1) : 378 - 378
[5] BevacizumabArterial hypertension: 2 case reports
Reactions Weekly, 2023, 1947 (1) : 105 - 105
[6] MethylphenidatePulmonary hypertension: 2 case reports
Reactions Weekly, 2015, 1578 (1) : 200 - 200
[7] AntineoplasticsThrombocytopenia and hypertension: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 63 - 63
[8] AntiretroviralsPulmonary hypertension: 2 case reports
Reactions Weekly, 2002, 915 (1) : 5 - 5
[9] BevacizumabPulmonary hypertension: 2 case reports
Reactions Weekly, 2009, 1280 (1) : 11 - 11
[10] RamucirumabAcute hypertension: 2 case reports
Reactions Weekly, 2016, 1622 (1) : 167 - 167

← 1 2 3 4 5 →